|4Nov 30, 5:16 PM ET

Char Daniel 4

4 · ImmunoGen, Inc. · Filed Nov 30, 2022

Insider Transaction Report

Form 4
Period: 2022-11-30
Char Daniel
SVP & CHIEF LEGAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-11-30$5.19/sh+400,000$2,076,000400,000 total
    Exercise: $5.19From: 2023-11-30Exp: 2032-11-30Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.

Documents

1 file
  • 4
    form4-11302022_101108.xmlPrimary